What is TTRX's quick ratio?

TTRX (TTRX) reported quick ratio of 2.2× in Q1 2026.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

TTRX TTRX Quick ratio

Quick ratio at other companies

Regeneron PharmaceuticalsREGN

3×-1.1×

Bausch Health CompaniesBHC

1×0.0×

Journey Medical CorporationDERM

1.5×+0.4×

PTH

Pelthos Therapeutics Inc.PTHS

1.9×+1.7×

Celldex TherapeuticsCLDX

8.9×-12.7×

Arcutis Biotherapeutics, Inc.ARQT

2.5×-0.9×

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

quick assets/total current liabilities=2.2×

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's quick ratio?: TTRX (TTRX) reported quick ratio of 2.2× in Q1 2026.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.